DXCM
Dexcom
$73.37
+$1.83 (+2.56%)Jul 27, 2026
Key metrics
The numbers that frame DXCM today
- Market cap
- $28.31B
- P/E (TTM)
- 30.4
- EV / FCF
- 20.0
- Gross margin
- 61.5%
- EV / Sales
- 5.9
- ROIC
- 25.6%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $54.11
- 52wk High
- $89.98
Growth
Revenue and earnings trend for DXCM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DXCM
Is Dexcom a good buy?
Yes. Dexcom has excellent quality, and it outweighs the weak momentum here. Growth looks strong, which supports the long-term business case. We think Dexcom is selling at a fair price.
What is the market capitalization of DXCM?
Dexcom's market capitalization is $28.31B.
What is the P/E ratio for DXCM stock?
Dexcom's current P/E ratio is 30.4.
What is the 52-week high for DXCM stock?
The 52-week high for Dexcom is $89.98. The current close of $73.37 is 18.5% below that high.
What is the 52-week low for DXCM stock?
The 52-week low for Dexcom is $54.11. The current close of $73.37 is 35.6% above that low.
Does DXCM stock pay dividends?
Dexcom does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DXCM?
Dexcom's Debt / Equity ratio is 0.45.